C4 Therapeutics CCCC
€ 3.80
-0.86%
Quartalsbericht 2024-Q3
hinzugefügt 31.10.2024
C4 Therapeutics Bilanz 2011-2024 | CCCC
Bilanz Jährlich C4 Therapeutics
2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
-15.9 M | -64 M | -171 M | -76.8 M | -21.8 M | - | - | - | - | - | - | - | |
Langfristige Schulden |
- | 9.2 M | 10.8 M | 10.1 M | - | - | - | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
5.22 M | 4.7 M | 1.33 M | 1.04 M | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | 75.5 M | 197 M | 202 M | - | - | - | - | - | - | - |
Kurzfristige Verbindlichkeiten |
42.8 M | 44.5 M | 51.2 M | 43.9 M | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
130 M | 142 M | 117 M | 119 M | 230 M | 226 M | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
15.5 M | 16.6 M | 31.8 M | 27.6 M | 20.7 M | 19.1 M | - | - | - | - | - | - | - |
Gewinnrücklagen |
-528 M | -396 M | -268 M | -184 M | -117 M | -83.4 M | - | - | - | - | - | - | - |
Vermögenswerte |
376 M | 431 M | 507 M | 400 M | 118 M | 146 M | - | - | - | - | - | - | - |
Zahlungsmittel |
127 M | 29.8 M | 76.1 M | 182 M | 90.5 M | 38.9 M | - | - | - | - | - | - | - |
Buchwert |
246 M | 289 M | 390 M | 281 M | -112 M | -79.8 M | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
246 M | 289 M | 390 M | 281 M | -112 M | -79.8 M | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich C4 Therapeutics
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
61.5 M | 62.9 M | 64.4 M | 65.8 M | - | - | 8.62 M | 9.2 M | 9.05 M | - | 10.2 M | 10.8 M | 10.6 M | 10.4 M | 10.2 M | 10.1 M | 10.1 M | 10.1 M | 10.1 M | 12.9 M | 12.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
133 M | 134 M | 140 M | 130 M | 117 M | 141 M | 134 M | 142 M | 143 M | - | 151 M | 117 M | 109 M | 112 M | 110 M | 119 M | 119 M | 119 M | 119 M | 119 M | 119 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
20.8 M | 36.6 M | 35.1 M | 15.5 M | 8.42 M | 14 M | 14.9 M | 16.6 M | 18.1 M | - | 31.3 M | 31.8 M | 32.3 M | 28.7 M | 26.6 M | 27.6 M | 27.6 M | 27.6 M | 27.6 M | 20.7 M | 20.7 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-599 M | -574 M | -557 M | -528 M | -494 M | -467 M | -431 M | -396 M | -359 M | - | -299 M | -268 M | -252 M | -227 M | -205 M | -184 M | -184 M | -184 M | -184 M | -117 M | -117 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
376 M | 381 M | 398 M | 376 M | 333 M | 375 M | 396 M | 431 M | 461 M | - | 515 M | 507 M | 508 M | 528 M | 374 M | 400 M | 400 M | 400 M | 400 M | 118 M | 118 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
59.6 M | 73.1 M | 89.7 M | 127 M | 61 M | 44.9 M | 49.5 M | 29.8 M | 49.6 M | 57.3 M | 46 M | 76.1 M | 163 M | 281 M | 94.9 M | 182 M | 182 M | 182 M | 182 M | 90.5 M | 90.5 M | - | - | 38.9 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
243 M | 247 M | 258 M | 246 M | 216 M | 234 M | 262 M | 289 M | 318 M | - | 365 M | 390 M | 399 M | 416 M | 264 M | 281 M | 281 M | 281 M | 281 M | -968 K | -968 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
243 M | 247 M | 258 M | 246 M | 216 M | 234 M | 262 M | 289 M | 318 M | 345 M | 365 M | 390 M | 399 M | 416 M | 264 M | 281 M | 281 M | 281 M | 281 M | -112 M | -112 M | -93.4 M | - | -79.8 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung